Ask AI
H.R. 6301

Cancer Drug Parity Act of 2023

A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.

Referred to the House Committee on Education and the Workforce.

Rep. Grothman, Glenn [R-WI-6](R-WI)Sponsor
27 cosponsors24 D3 R
27cosponsors1committees3actions1related bills
  1. IntroReferralH11100

    Referred to the House Committee on Education and the Workforce.

    Education and Workforce Committee
  2. IntroReferralIntro-H

    Introduced in House

  3. IntroReferral1000

    Introduced in House

Cancer Drug Parity Act of 2023 — Informed